What's New in October: STAT!Ref Supplemental Updates

©2009 American Society of Health-System Pharmacists
Authors/Editors: Gerald K. McEvoy, Pharm.D. and Elaine K. Snow, B.S. Pharm.
With the 2009 edition, the American Hospital Formulary Service® (AHFS™) marks over 50 years of continuous publication by the American Society of Health-System Pharmacists (ASHP). Each year, an average of over 60% of AHFS content is revised to help you provide the most accurate recommendations for your patients’ drug therapy.
AHFS references are evidence-based and peer-reviewed, compiled without the influence of manufacturers, insurers, regulators or other interested parties. No other drug information sources can make this claim.
AHFS DI has been designated as an official compendium by the US Congress.
AHFS DI contains information from medical literature and expert advice from over 500 medical scientists, physicians, pharmacists, pharmacologists and other professionally qualified individuals that goes beyond FDA-approved labeling.
What's New in October 2009
New Monographs:
- Influenza A (H1N1) Vaccine Inactivated
- Influenza A (H1N1) Vaccine Live Intranasal
- Regadenoson
- Sinecatechins
Revised Monographs:
- Adalimumab
- Aldesleukin
- Atorvastatin
- Carbamazepine
- Certolizumab Pegol
- Daunorubicin
- Delavirdine
- Didanosine
- Enfuvirtide
- Etanercept
- Hepatitis B Immune Globulin
- Hepatitis B Vaccine Recombinant
- Ibritumomab
- Imatinib
- Indinavir
- Infliximab
- Influenza Virus Vaccine Inactivated
- Influenza Virus Vaccine Live Intranasal
- Irbesartan
- Lopinavir and Ritonavir
- Natalizumab
- Nevirapine
- Olmesartan
- Oseltamivir
- Promethazine
- Promethazine (Antihistamine)
- Saquinavir
- Sitagliptin
- Stavudine
- Valsartan

Medical Letter® On Drugs and Therapeutics, The
©2009-1995 The Medical Letter, Inc.
Authors/Editors: Mark Arbramwicz, MD et. al.
The Medical Letter on Drugs and Therapeutics is an independent, nonprofit publication that offers unbiased critical evaluations of drugs for physicians and other members of the health professions. This resource evaluates virtually all new drugs and also reviews older drugs when important new information becomes available on their usefulness or adverse effects. It is only available to single users online and covers the period from 1995-2008.*
What's New for October 19, 2009, Issue 1323
Generic Drugs Revisited [51:1323]
Degarelix (Firmagon) for Prostate Cancer [51:1323]
Recombinant Human Antithrombin (ATryn) [51:1323]

©2009 by the American College of Physicians
Authors/Editors: Brian Haynes, MD, PhD
ACP Journal Club, published by the American College of Physicians, is the quintessential EBM journal, and is often positioned near the top of the EBM pyramid.
The combination of ACP Journal Club and PIER provides us with the potential to deliver an EBM product that is superior to competitive offerings. ACP Journal Club is published 6 times per year.
Purpose of ACP Journal Club: "ACP Journal Club's general purpose is to select from the biomedical literature articles that report original studies and systematic reviews that warrant immediate attention by physicians attempting to keep pace with important advances in internal medicine. These articles are summarized in value-added abstracts and commented on by clinical experts."
What's New in October 2009 - Volume 151, Number 4
Therapeutics
Review: Preoperative smoking cessation interventions reduce postoperative complications Adding prompt revascularization to medical therapy did not reduce mortality or CV events in patients with type 2 diabetes and CAD Minimally invasive and conventional glucose monitoring did not differ for long-term glycemic control in insulin-treated diabetes Rosiglitazone was noninferior to metformin plus sulfonylurea for CV events but increased risk for HF and fractures in type 2 diabetes Graduated compression stockings did not prevent deep venous thrombosis after stroke and increased skin complications Review: Evidence for the effectiveness of nonsurgical interventions for low back pain and radiculopathy is limited Review: Evidence for the effectiveness of surgery for low back pain, radiculopathy, and spinal stenosis is limited Quadrivalent HPV vaccine reduced risk for HPV infection and related disease in women 24 to 45 years of age Review: Amiodarone reduces risk for sudden cardiac death but not all-cause mortality in cardiomyopathy Review: Statins reduce mortality and cardiovascular events in adults at risk for cardiovascular disease
Diagnosis Contrast-enhanced magnetic resonance angiography is the most accurate noninvasive imaging technique for carotid stenosis










Entamoeba histolytica trophozoite, trichrome stain